• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Brazil Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Brazil Pharmaceuticals and Healthcare Report Q1 2013

  • Published: January 2013
  • Region: Brazil
  • 192 pages
  • Business Monitor International

FEATURED COMPANIES

  • Aché/Biosintética
  • Cristália
  • Eurofarma
  • Medley
  • Novartis
  • Roche
  • MORE

BMI View: The Brazilian pharmaceutical market remains our favourite regional market in Latin America due to its large market size and strong domestic demand for innovative, high-tech products. The government is increasingly investing in the healthcare sector and pharmaceutical industry to reduce the financial burden of diseases, and the country's private healthcare sectors provide opportunities for foreign companies. However, the increasing drug rebate level has significantly undermined the profits recorded by generic drugmakers. The more aggressive government techonology transfer deals with multinationals as well as the drug approval delays due to bureaucracy and staff shortages at ANVISA have also dampened multinationals' revenue-generating opportunities

Headline Expenditure Projections

- Pharmaceuticals: BRL48.10bn (US$28.72bn) in 2011 to BRL51.76bn (US$25.88bn) in 2012;
+7.6% in local currency terms and -9.9% in US dollars terms. Forecast down from Q412 due to less optimistic industry projections.

- Healthcare: BRL378.63bn (US$226.04bn) in 2011 to BRL416.46bn (US$208.23bn) in 2012;
+10.0% in local currency terms and -7.9% in US dollars. Forecast upwards READ MORE >

Executive Summary 7

SWOT Analysis 10

Brazil Pharmaceuticals And Healthcare Industry SWOT 10

Brazil Political SWOT 11

Brazil Economic SWOT 12

Brazil Business Environment SWOT 13

Pharmaceutical Risk/Reward Ratings 14
Table: Americas Pharmaceutical Risk/Reward Ratings, Q113 14

Brazil - Market Summary 16

Regulatory Regime 18

Intellectual Property Environment 25

Counterfeits 28

Compulsory Licensing 29

Pricing Regime 30

Reimbursement Regime 34
Table: Medicines In The Partnership Deals 36

OTC Regulations 39

Advertising 41

Industry Developments 43

Epidemiology 43

Healthcare Sector 45

Healthcare Sector Funding 47

Research And Development 48

Biotechnology 51

Clinical Trials 58

Medical Devices Market 58

Medical Device Industry - Recent Developments 60

Medical Device Distribution 60

Industry Forecast Scenario 61

Overall Market Forecast 61
Table: Brazil Pharmaceutical Sales, Historical Data And Forecasts 62

Key Growth Factors - Industry 63
Table: Brazil Healthcare Expenditure Trends, Historical Data And Forecasts 65
Table: Brazil Government Healthcare Expenditure Trends, Historical Data And Forecasts 65
Table: Brazil Private Healthcare Expenditure Trends, Historical Data And Forecasts 66

Key Growth Factors - Macroeconomic 67
Table: Brazil - Economic Activity 72

Prescription Drug Market Forecast 73
Table: Brazil Prescription Drug Market Indicators, Historical Data And Forecasts 74

Patented Drug Market Forecast 75
Table: Brazil Patented Drug Market Indicators, Historical Data And Forecasts 76

Generic Drug Market Forecast 77
Table: Brazil Generics Drug Market Indicators, Historical Data And Forecasts 80
Table: Cumulative Active Ingredients, Registrations & Presentations Of Generics, 2000-April 2012 81
Table: Top-12 Leading Brands Losing Patent, 2012 82

OTC Medicine Market Forecast 84
Table: Brazil Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts 85

Pharmaceutical Trade Forecast 86
Table: Brazil Pharmaceutical Trade Data And Forecasts (US$mn) 88
Table: Brazil Pharmaceutical Trade Data And Forecasts (BRLmn) 89

Medical Device Market Forecast 90
Table: Brazil Medical Device Market Indicators, Historical Data And Forecasts 91

Other Healthcare Data 92

Key Risks To BMI's Forecast Scenario 92

Competitive Landscape 93

Pharmaceutical Industry 93

Top 20 Pharmaceutical Companies In Brazil By Sales In 2010 93

Innovative Drugmakers 94

Innovative Drugmakers - Recent Developments 94
Table: Members of ABIMIP, 2011 96
Table: Members Of INTERFARMA, 2011 97

Generic Drugmakers 06
Table: Members Of ALANAC, 2011 08
Table: Members Of ALFOB, 2011 09

Members Of Pró-Genéricos, 2011 10

Hypermarcas' Major Acquisitions, 2005-11 22
Table: Hypermarcas' Net Sales By Division, 2009-10 (R$mn) 23

OTC Sector 27

Pharmaceutical Distribution Sector 27
Table: Members Of ABAFARMA, 2012 29

Members Of ABRADILAN, 2012 30

Profarma's Net & Gross Sales, 2005-11 (R$mn) 36
Table: Profarma's Distribution Centres By Location, 2012 37

Santa Cruz's Distribution Centres By 37

Pharmaceutical Retail Sector 38
Table: ABRAFARMA's Ranking Of Pharmacy Chains By Sales, 2010-11 42
Table: ABRAFARMA's Ranking Of Pharmacy Chains By Number Of Outlets, 2010-11 43
Table: ABRAFARMA's Financial Indicators, 2008-11 44
Table: Members Of ABRAFARMA, 2012 45
Table: Members Of ASSIFARMA, 2012 46
Table: Members Of FEBRAFAR By Region, 2012 46
Table: Pague Menos' Gross Sales, 2000-11 51
Table: RaiaDrogasil's Gross Sales, 2001-11 (R$mn) 53
Table: RaiaDrogasil's Number Of Pharmacies, 2001-12 54

Company Profiles 155

Aché/Biosintética 55

EMS Sigma 58

Eurofarma 60

Medley 62

Cristália 64

Sanofi 66

Pfizer 68

Merck & Co 71

Novartis 74

GlaxoSmithKline 77

Roche 80

Demographic Outlook 182
Table: Brazil's Population By Age Group, 1990-2020 ('000) 83
Table: Brazil's Population By Age Group, 1990-2020 (% of total) 84
Table: Brazil's Key Population Ratios, 1990-2020 85
Table: Brazil's Rural And Urban Population, 1990-2020 85

Glossary 186

BMI Methodology 188

How We Generate Our Pharmaceutical Industry Forecasts 88

Pharmaceuticals Business Environment Ratings 89

Risk/Reward Ratings Methodology 89

Ratings Overview 89
Table: Pharmaceutical Business Environment Indicators 90

Weighting 91
Table: Weighting Of Components 91

Sources 91

Company Profiles
Aché/Biosintética
EMS Sigma
Eurofarma
Medley
Cristália
Sanofi
Pfizer
Merck & Co
Novartis
GlaxoSmithKline
Roche

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos